William Harvey Research Foundation
William Harvey Research addresses areas of unmet need in pharmacology and the life sciences, with a focus on early-stage research in cardiovascular disease, endocrine disorders, genomics and inflammation.
We exist because funding is limited for early-stage research: very few charities focus on this. Our research addresses many targets (for common and for rare diseases) where there is at present little or no effective treatment.
Statistics that put our research in perspective include the following: 60% of people over 65 in the UK suffer from heart disease; over 6000 patients are waiting to receive organ transplants, and these usually last on 10-15 years; 350,000 children’s lives are debilitated through heart conditions.
Innovative research at WHR is focussed on the advancement of knowledge and the development of new treatments, with the aim of improving these statistics.
Our focus on early-stage, pioneering research is performed at world-leading pharmacology centre, the William Harvey Research Institute. We advance medical knowledge, increase success in clinical trials, and create the potential for new treatments.
WHR’s robust financial model ensures 100% of all donations are used entirely to support research.
William Harvey Research comprises the William Harvey Research Foundation (the charitable arm), William Harvey Research Institute, and William Harvey Research Limited.